Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
June 30, 2016

M&As this week: TBG Diagnostics, Charles River

TBG Diagnostics has announced that it will acquire a 51% stake in RBC Biosciences Corp. for a purchase consideration of $4m.

TBG Diagnostics has announced that it will acquire a 51% stake in RBC Biosciences Corp. for a purchase consideration of $4m.

The acquisition is expected to be completed by August 2016 and will provide TBG Diagnostics with sales and distribution opportunities in the global diagnostics market.

Charles River Laboratories International has acquired Blue Stream Laboratories to develop its biological testing solutions business to compete in the growing market segment.

According to the agreement, Blue Stream Labs will be combined with Charles River Labs’ discovery, safety assessment and biologics capabilities to develop biologics and biosimilars from characterisation through clinical testing and commercialisation.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU